Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

This study has been terminated.
(Sponsor decision)
Sponsor:
Information provided by (Responsible Party):
Avexa
ClinicalTrials.gov Identifier:
NCT00612898
First received: January 30, 2008
Last updated: January 19, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)